Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Preprint en Inglés | medRxiv | ID: ppmedrxiv-22275326

RESUMEN

We enrolled seven individuals with recurrent symptoms following nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log10 copies/mL) were detected at enrollment and for a median of 17 days after initial diagnosis. Three of seven had culturable virus for up to 16 days after initial diagnosis. No known resistance-associated mutations were identified.

2.
Preprint en Inglés | medRxiv | ID: ppmedrxiv-22271731

RESUMEN

There is increasing evidence that the risk of SARS-CoV-2 infection among vaccinated individuals is variant-specific, suggesting that protective immunity against SARS-CoV-2 may differ by variant. We enrolled vaccinated (n = 39) and unvaccinated (n = 11) individuals with acute, symptomatic SARS-CoV-2 Delta or Omicron infection and performed SARS-CoV-2 viral load quantification, whole-genome sequencing, and variant-specific antibody characterization at the time of acute illness and convalescence. Viral load at the time of infection was inversely correlated with antibody binding and neutralizing antibody responses. Increases in antibody titers and neutralizing activity occurred at convalescence in a variant-specific manner. Across all variants tested, convalescent neutralization titers in unvaccinated individuals were markedly lower than in vaccinated individuals. For individuals infected with the Delta variant, neutralizing antibody responses were weakest against BA.2, whereas infection with Omicron BA.1 variant generated a broader response against all tested variants, including BA.2.

3.
Preprint en Inglés | medRxiv | ID: ppmedrxiv-22271582

RESUMEN

Clinical features of SARS-CoV-2 Omicron variant infection, including incubation period and transmission rates, distinguish this variant from preceding variants. However, whether the duration of shedding of viable virus differs between omicron and previous variants is not well understood. To characterize how variant and vaccination status impact shedding of viable virus, we serially sampled symptomatic outpatients newly diagnosed with COVID-19. Anterior nasal swabs were tested for viral load, sequencing, and viral culture. Time to PCR conversion was similar between individuals infected with the Delta and the Omicron variant. Time to culture conversion was also similar, with a median time to culture conversion of 6 days (interquartile range 4-8 days) in both groups. There were also no differences in time to PCR or culture conversion by vaccination status.

4.
Preprint en Inglés | medRxiv | ID: ppmedrxiv-20103226

RESUMEN

ObjectivesPublic health interventions designed to interrupt COVID-19 transmission could have deleterious impacts on primary healthcare access. We sought to identify whether implementation of the nationwide lockdown (shelter-in-place) order in South Africa affected ambulatory clinic visitation in rural Kwa-Zulu Natal (KZN). DesignProspective, longitudinal cohort study SettingData were analyzed from the Africa Health Research Institute Health and Demographic Surveillance System, which includes prospective data capture of clinic visits at eleven primary healthcare clinics in northern KwaZulu-Natal ParticipantsA total of 36,291 individuals made 55,545 clinic visits during the observation period. Exposure of InterestWe conducted an interrupted time series analysis with regression discontinuity methods to estimate changes in outpatient clinic visitation from 60 days before through 35 days after the lockdown period. Outcome MeasuresDaily clinic visitation at ambulatory clinics. In stratified analyses we assessed visitation for the following sub-categories: child health, perinatal care and family planning, HIV services, noncommunicable diseases, and by age and sex strata. ResultsWe found no change in total clinic visits/clinic/day from prior to and during the lockdown (-6.9 visits/clinic/day, 95%CI -17.4, 3.7) or trends in clinic visitation over time during the lockdown period (-0.2, 95%CI -3.4, 3.1). We did detect a reduction in child healthcare visits at the lockdown (-7.2 visits/clinic/day, 95%CI -9.2, -5.3), which was seen in both children <1 and children 1-5. In contrast, we found a significant increase in HIV visits immediately after the lockdown (8.4 visits/clinic/day, 95%CI 2.4, 14.4). No other differences in clinic visitation were found for perinatal care and family planning, non-communicable diseases, or among adult men and women. ConclusionsIn rural KZN, the ambulatory healthcare system was largely resilient during the national-wide lockdown order. A major exception was child healthcare visitation, which declined immediately after the lockdown but began to normalize in the weeks thereafter. Future work should explore efforts to decentralize chronic care for high-risk populations and whether catch-up vaccination programs might be required in the wake of these findings. What is already known on this topic?O_LIPrior disease epidemics have created severe interruptions in access to primary care in sub-Saharan Africa, resulting in increased child and maternal mortality C_LIO_LIData from resource-rich settings and modelling studies have suggested the COVID-19 epidemic and non-pharmacologic measures implemented in response could similarly result in substantial barriers to primary health care access in the region C_LIO_LIWe leveraged a clinical information system in rural KwaZulu-Natal to empirically assess the effect of the COVID-19 epidemic and a nationwide lockdown in South Africa on access to primary care C_LI What this study adds?O_LIAccess to primary healthcare was largely maintained during the most stringent period of the COVID-19 lockdown in South Africa, with the exception of a temporary drop in child health visits C_LIO_LICreative solutions are needed for sustaining child vaccination programs, and protecting high-risk individuals from risk of nosocomial transmission in resource-limited settings C_LI

5.
Preprint en Inglés | medRxiv | ID: ppmedrxiv-20052373

RESUMEN

BackgroundSocial distancing measures to address the U.S. coronavirus disease 2019 (COVID-19) epidemic may have notable health and social impacts. Methods and FindingsWe conducted a longitudinal pretest-posttest comparison group study to estimate the change in COVID-19 case growth before versus after implementation of statewide social distancing measures in the U.S. The primary exposure was time before (14 days prior to, and up to 3 days after) versus after (beginning 4 days after, and up to 21 days after) implementation of the first statewide social distancing measures. Statewide restrictions on internal movement were examined as a secondary exposure. The primary outcome was the COVID-19 case growth rate. The secondary outcome was the COVID-19-attributed mortality growth rate. All states initiated social distancing measures between March 10-25, 2020. The mean daily COVID-19 case growth rate decreased beginning four days after implementation of the first statewide social distancing measures, by 0.9% per day (95% confidence interval [CI], -1.3% to -0.4%; P<0.001). We did not estimate a statistically significant difference in the mean daily case growth rate before versus after implementation of statewide restrictions on internal movement (0.1% per day; 95% CI, -0.04% to 0.3%, P=0.14), but there is significant difficulty in disentangling the unique associations with statewide restrictions on internal movement from the unique associations with the first social distancing measures. Beginning seven days after social distancing, the COVID-19-attributed mortality growth rate decreased by 1.7% per day (95% CI, -3.0% to -0.7%; P<0.001). Our analysis is susceptible to potential bias resulting from the aggregate nature of the ecological data, potential confounding by contemporaneous changes (e.g., increases in testing), and potential underestimation of social distancing due to spillovers across neighboring states. ConclusionsStatewide social distancing measures were associated with a decrease in the COVID-19 epidemic case growth rate that was statistically significant and a decrease in the COVID-19-attributed mortality growth rate that was not statistically significant. Author SummaryO_ST_ABSWhy was the study doneC_ST_ABSThere are few empirical data about the population health benefits of imposing statewide social distancing measures to reduce transmission of severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19). What did the researchers findWe compared data from each state before vs. after implementation of statewide social distancing measures to estimate changes in mean COVID-19 daily case growth rates. Growth rates declined by approximately 1% per day beginning four days (approximately one incubation period) after statewide social distancing measures were implemented. Stated differently, our model implies that social distancing reduced the total number of COVID-19 cases by approximately 1,600 reported cases at 7 days after implementation, by approximately reported 55,000 cases at 14 days after implementation, and by approximately reported 600,000 cases at 21 days after implementation. What do these findings meanStatewide social distancing measures were associated with a reduction in the growth rate of COVID-19 cases in the U.S. However, our analysis is susceptible to potential bias resulting from the aggregate nature of the data, potential confounding by other changes that occurred during the study period (e.g., increases in testing), and potential underestimation of social distancing due to spillovers across neighboring states.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA